BR9710830A - Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. - Google Patents
Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein.Info
- Publication number
- BR9710830A BR9710830A BR9710830-8A BR9710830A BR9710830A BR 9710830 A BR9710830 A BR 9710830A BR 9710830 A BR9710830 A BR 9710830A BR 9710830 A BR9710830 A BR 9710830A
- Authority
- BR
- Brazil
- Prior art keywords
- begf
- recombinant
- protein
- production
- growth factor
- Prior art date
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
<B>Patente de invenção para o ''PROCESSO PARA PRODUçãO DE FATOR DE CRESCIMENTO DO VìRUS BEAN 58058 (BEGF) RECOMBINANTE E DA PROTEìNA DO BEGF RECOMBINANTE'' A presente invenção diz respeito ao processo de produção da proteína fator de crescimento do vírus BeAn 58058 (BEGF) recombinante produzida através de técnicas de engenharia genética e da proteína BEGF recombinante, para ser empregada em uso clínico médico ou veterinário ou em pesquisa. O DNA contendo o gene que codifica a proteína BEGF foi obtido realizando-se as seguintes etapas: Amplificação do DNA, (1), Clonagem (2), Transformação (3) Sequenciamento (4) Produção da proteína (5), Purificação da proteína. (6)<B> Invention patent for the '' PROCESS FOR THE PRODUCTION OF GROWTH FACTOR OF THE RECOMBINANT VIRUS BEAN 58058 (BEGF) AND THE RECOMBINANT BEGF PROTEIN '' The present invention relates to the production process of the BeAn virus growth factor protein 58058 (BEGF) recombinant produced using genetic engineering techniques and recombinant BEGF protein, to be used in clinical medical or veterinary use or in research. The DNA containing the gene encoding the BEGF protein was obtained by performing the following steps: DNA amplification, (1), Cloning (2), Transformation (3) Sequencing (4) Protein production (5), Protein purification . (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9710830-8A BR9710830A (en) | 1997-12-30 | 1997-12-30 | Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9710830-8A BR9710830A (en) | 1997-12-30 | 1997-12-30 | Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9710830A true BR9710830A (en) | 2000-05-23 |
Family
ID=4068867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9710830-8A BR9710830A (en) | 1997-12-30 | 1997-12-30 | Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. |
Country Status (1)
Country | Link |
---|---|
BR (1) | BR9710830A (en) |
-
1997
- 1997-12-30 BR BR9710830-8A patent/BR9710830A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511118A (en) | untranscribed haemophilus influenzae polypeptides | |
ES2134198T3 (en) | MUTATIONS IN THE 5 'TO 3' EXONUCLEASE OF DNA POLYMERASES. | |
BR9913360A (en) | Urate oxidase | |
ATE192500T1 (en) | RECOMBINANT VIRUS VECTORS FOR EXPRESSION IN MUSCLE CELLS | |
NO973685L (en) | Multi-tumor aberrant growth genes | |
TR200401186T4 (en) | Artificial chromosome structures containing nucleic acid sequences capable of directing the formation of a recombinant RNA-virus. | |
BR9610511A (en) | Circularly shaped DNA molecule useful in gene therapy comprising at least one nucleic sequence of interest process for its production recombinant cell pharmaceutical composition use of a DNA molecule and process for the production of a recombinant protein | |
BR9803960A (en) | D-sorbitol dehydrogenase gene. | |
ATE88500T1 (en) | DNA SEQUENCES CODING FOR PROTEINS WITH THE BIOLOGICAL ACTIVITY OF THE HUSI-TYPE INHIBITORS, GENETIC METHODS FOR THE PRODUCTION OF THESE PROTEINS, AND PHARMACEUTICALS CONTAINING THESE PROTEINS. | |
ATE412736T1 (en) | RETROVIRUS FROM THE HIV GROUP AND ITS USE | |
DE3856240T2 (en) | PRODUCTION OF P1 PROTEINS AND VACCINE AGAINST GONORRHEA | |
DE69736276D1 (en) | HUMAN DNASE RESISTANT AGAINST ACTININHIBITORS | |
DK0771352T3 (en) | Non-typeable Haemophilus influenza LKP peak adhesin protein and nucleic acid | |
BR9710830A (en) | Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. | |
Holtet et al. | Receptor‐binding domain of human α2‐macroglobulin Expression, folding and biochemical characterization of a high‐affinity recombinant derivative | |
PT704527E (en) | DNA sequencing that encodes BIOSAETIC INSULIN PRECURSORS AND PROCESS FOR THE PREPARATION OF INSULIN | |
DE69529750D1 (en) | IMPROVEMENTS IN THE PRODUCTION OF PROTEINS IN HOST CELLS | |
PT1322753E (en) | NEW REDUCTIONS OF 2,5-DICETO-L-GLUCONIC ACID AND METHODS OF USE | |
BR0002493A (en) | Process for the preparation of l-amino acids by fermentation and nucleotide sequences encoding the accda gene | |
DE69031996D1 (en) | HUMAN RECOMBINANT PLACENTAL RIBONUCLEASE INHIBITOR AND METHOD FOR THE PRODUCTION THEREOF | |
Ikeuchi et al. | The enhancing of a cysteine proteinase activity at acidic pH by protein engineering, the role of glutamic 50 in the enzyme mechanism of caricain | |
DE69730967D1 (en) | Human dnase ii | |
WO1999052947A3 (en) | TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) | |
BR9710828A (en) | Process for the production of recombinant human beta-cis interferon protein and recombinant human beta-cis interferon protein | |
Dodson | Fred Sanger: sequencing pioneer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15Z | Prolongation of time limit refused |
Free format text: NEGADA A SOLICITACAO DE DEVOLUCAO DE PRAZO UMA VEZ QUE A MESMA NAO FOI APRESENTADA AO INPI NA VIGENCIA DO PRAZO PREVISTO PARA A PRATICA DO ATO, CONFORME DEFINIDO NO ART. 221 DA LPI. A COPIA DO PARECER (DAS RAZOES) PODERA SER SOLICITADA ATRAVES DO FORMULARIO 1.05. (DESTA DATA CORRE O PRAZO DE 60 (SESSENTA) DIAS PARA EVENTUAL RECURSO DO INTERESSADO). |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA 12A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2207 DE 24/04/2013. |